1. Home
  2. PRPO vs HUGE Comparison

PRPO vs HUGE Comparison

Compare PRPO & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • HUGE
  • Stock Information
  • Founded
  • PRPO N/A
  • HUGE 1998
  • Country
  • PRPO United States
  • HUGE Canada
  • Employees
  • PRPO N/A
  • HUGE N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPO Industrials
  • HUGE Health Care
  • Exchange
  • PRPO Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • PRPO 8.8M
  • HUGE 7.8M
  • IPO Year
  • PRPO N/A
  • HUGE N/A
  • Fundamental
  • Price
  • PRPO $4.69
  • HUGE $0.14
  • Analyst Decision
  • PRPO
  • HUGE
  • Analyst Count
  • PRPO 0
  • HUGE 0
  • Target Price
  • PRPO N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • PRPO 5.7K
  • HUGE 2.4M
  • Earning Date
  • PRPO 08-15-2024
  • HUGE 07-22-2024
  • Dividend Yield
  • PRPO N/A
  • HUGE N/A
  • EPS Growth
  • PRPO N/A
  • HUGE N/A
  • EPS
  • PRPO N/A
  • HUGE N/A
  • Revenue
  • PRPO $15,812,000.00
  • HUGE N/A
  • Revenue This Year
  • PRPO $75.18
  • HUGE N/A
  • Revenue Next Year
  • PRPO N/A
  • HUGE N/A
  • P/E Ratio
  • PRPO N/A
  • HUGE N/A
  • Revenue Growth
  • PRPO 61.64
  • HUGE N/A
  • 52 Week Low
  • PRPO $4.31
  • HUGE $0.13
  • 52 Week High
  • PRPO $8.99
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 34.21
  • HUGE 28.34
  • Support Level
  • PRPO $4.73
  • HUGE $0.14
  • Resistance Level
  • PRPO $5.14
  • HUGE $0.15
  • Average True Range (ATR)
  • PRPO 0.34
  • HUGE 0.02
  • MACD
  • PRPO -0.02
  • HUGE 0.01
  • Stochastic Oscillator
  • PRPO 31.40
  • HUGE 18.57

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: